BiotechTube
Home/PuREC/Dr. Tomohiro Anzai
DT

Dr. Tomohiro Anzai

Independent Director

PuREC

Therapeutic Areas

CardiovascularMusculoskeletal

PuREC Pipeline

DrugIndicationPhase
REC-01Hypophosphatasia (HPP)Phase 1/2a
REC-MSC for Spinal Canal StenosisSpinal Canal StenosisPreclinical
REC-MSC for Joint DiseasesOsteoarthritis/Joint DiseasesDiscovery

Leadership Team at PuREC

HT
Hide Takahashi
CEO
DS
Dr. Shotai Kobayashi
Executive Chair
DY
Dr. Yumi Matsuzaki
Founder & CSO
View full PuREC profile